Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1970 1
1976 1
1982 1
1984 1
1985 2
1986 1
1987 1
1988 2
1989 1
1992 4
1993 2
1994 3
1995 3
1996 2
1997 3
1998 1
1999 1
2000 2
2001 2
2002 1
2003 3
2004 4
2005 4
2006 3
2007 6
2008 6
2009 6
2010 6
2011 5
2012 10
2013 24
2014 20
2015 24
2016 14
2017 17
2018 26
2019 28
2020 20
2021 37
2022 40
2023 37
2024 36
2025 45
2026 27

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

451 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean burger am[au] (230 results)?
Genetic and pharmacological inactivation of peptidoglycan remodeling increases antibiotic susceptibility of vancomycin-resistant Enterococcus faecium.
Fam KT, Chodisetti PK, Wang Z, Homer JA, Smedley CJ, Kitamura S, Silva B, Xiong Y, Hansel-Harris A, Holcomb M, Babarinde S, Turner AM, Van Tyne D, Wilson IA, Forli S, Cravatt BF, Park D, Wolan DW, Moses JE, Hang HC. Fam KT, et al. Among authors: turner am. Nat Commun. 2026 Jun 16. doi: 10.1038/s41467-026-74057-1. Online ahead of print. Nat Commun. 2026. PMID: 42297812 Free article.
Ivermectin for Critically and Noncritically Ill Hospitalized Patients With COVID-19: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP).
Hashmi M, Haniffa R, Jayakumar D, Beane A, Lorenzi E, Berry LR, Nasir Khoso M, Ain Khan Q, Kumar A, Altaf Kidwai A, Hills TE, Annane D, Aryal D, Au C, Baillie K, Beasley R, Best-Lane J, Bonten M, Bradbury CA, Brunkhorst FM, Burrell A, Buxton M, Cecconi M, Cheng AC, Cove ME, de Jong M, Detry MA, Duffy E, Estcourt LJ, Fitzgerald M, Fowler R, Goossens H, Green C, Hays LMC, Higgins AM, Huang DT, Ichihara N, Koirala S, Lamontagne F, Lawler PR, Lewis RJ, Litton E, Mahon N, Marshall JC, McAuley DF, McGlothlin A, McGuinness S, McQuilten ZK, McVerry BJ, Mouncey PR, Morpeth S, Netea M, Orr K, Parke RL, Parker JC, Patanwala A, Peters S, Reyes LF, Rowan KM, Saito H, Saunders CT, Santos M, Seymour CW, Shankar-Hari M, Singh V, Slater M, Tambyah PA, Tong SYC, Turgeon AF, Turner AM, van de Veerdonk F, Weis S, Zarychanski R, McArthur CJ, Angus DC, Berry SM, Gordon AC, Derde LPG, Webb SA, Murthy S, Arabi Y, Nichol AD; and the Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP) Investigators. Hashmi M, et al. Among authors: turner am. Crit Care Med. 2026 May 8. doi: 10.1097/CCM.0000000000007134. Online ahead of print. Crit Care Med. 2026. PMID: 42101205
Intermediate dose heparin thromboprophylaxis among critically ill patients with COVID-19: a randomized clinical trial.
Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia (REMAP-CAP) Investigators; Bradbury CA, McVerry BJ, Lawler PR, Angus DC, Annane D, Arabi YM, Aryal D, Au C, Beane A, Berry SM, Berry LR, Best-Lane J, Bihari S, Bonten M, Brunkhorst F, Burrell A, Buxton M, Carrier M, Cecconi M, Cheng AC, Cove M, Derde LPG, Detry MA, Estcourt LJ, Fergusson DA, Fitzgerald M, Fowler RA, Goligher EC, Green C, Haniffa R, Harrison DA, Hays LMC, Higgins AM, Hills T, Horvat CM, Huang DT, Hunt BJ, Ichihara N, Jayakumar D, Keattch S, Kumar A, Laffan MA, Lamontagne F, Leeper CM, Lewis RJ, Lorenzi E, Lother SA, Marshall JC, McArthur CJ, McAuley DF, McGlothlin A, McGuinness SP, McQuilten ZK, Middeldorp S, Morpeth S, Mouncey PR, Murthy S, Neal MD, Nichol AD, Parke RL, Parker JC, Peters S, Reyes LF, Rowan K, Saito H, Santos M, Saunders CT, Schutgens REG, Seymour CW, Hari MS, Singh V, Stanworth SJ, Turgeon AF, Turner AM, van de Veerdonk FL, Gordon AC, Webb SA, Zarychanski R. Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia (REMAP-CAP) Investigators, et al. Among authors: turner am. J Thromb Haemost. 2026 Mar 25:S1538-7836(26)00191-1. doi: 10.1016/j.jtha.2026.03.006. Online ahead of print. J Thromb Haemost. 2026. PMID: 41895526 Free article.
451 results